prescriptions
Recent Rosacea Blog Posts
Teva Generics has announced that they are now selling a generic version of Soolantra, branded as Ivermectin Cream 1%. This generic formulation of Ivermectin is indicated for the treatment of inflammatory lesions of rosacea – that is the papules and pustules common to rosacea sufferers. Teva Announces the U.S. Launch of its Generic Version of […]
An interesting graphic emerged from a recent presentation from Menlo Therapeutics, the owners of the recently approved rosacea treatment Zilxi. Menlo quote from statistics showing the typical growth of rosacea prescription sales 1 year and 3 years after a product is approved. Oracea Sales Increasing Here you can see that Oracea is the stand out […]
The publicity around the launch for Zilxi, the new 1.5% topical minocycline based treatment for rosacea contains confirmation that the list price for a 30gm prescription will be $485. Now known as VYNE Therapeutics, the makers of Zilxi are preparing to make their recently FDA approved treatment for the papules and pustules of rosacea available […]
So you have heard something about the new phenotype approach to treating roscea. Doctors are hoping that this new approach will lead to better treatment outcomes for all rosacea sufferers. Find out what here you need to know about rosacea phenotypes, and also how you can use a simple report card to work together […]
This just published article is describing some clinical work has been concluded that proposes using topical Ivermectin (Soolantra) to treat ocular rosacea. Soolantra so far has only been approved as a treatment for the papules and pustules of rosacea. Soolantra is thought to be effective against rosacea because of its anti-demodex and anti-inflammatory properties. […]
